| Literature DB >> 4270794 |
E Dvornik, N Simard-Duquesne, M Krami, K Sestanj, K H Gabbay, J H Kinoshita, S D Varma, L O Merola.
Abstract
An orally active inhibitor of aldose reductase, 1,3-dioxo-1H-benz[de]-isoquinoline-2(3H)acetic acid (AY-22,284), prevented cataractous changes in cultured lenses exposed to high concentrations of galactose. When given orally, AY-22,284 markedly decreased the accumulation of polyols in the lenses and sciatic nerves of galactosemic rats and rats with streptozotocin-induced diabetes. In addition, treatment of galactosemic rats with AY-22,284 effectively suppressed the formation of cataracts.Entities:
Mesh:
Substances:
Year: 1973 PMID: 4270794 DOI: 10.1126/science.182.4117.1146
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728